Veeva Systems (VEEV)
NYSE Market Closed
Veeva Systems Inc. provides cloud software built specifically for the life sciences industry. Its customers include pharmaceutical companies, biotechnology developers, contract research organizations, and medical technology businesses that need systems designed around regulated sales, clinical, quality, regulatory, and content workflows.
The company’s commercial software roots are in Veeva CRM, a customer relationship management platform used by life sciences sales and medical teams to manage interactions with healthcare professionals and other stakeholders. Veeva is also expanding around Vault CRM, which brings commercial customer engagement into its broader Vault platform. Veeva Vault is a suite of cloud applications and content management tools that supports functions such as clinical operations, regulatory submissions, quality management, safety, medical affairs, and promotional materials.
Veeva’s distinction is its industry-specific focus. Rather than selling generic enterprise software that life sciences companies must heavily customize, Veeva designs applications around the compliance, documentation, and process requirements of drug and device development and commercialization. This helps customers replace older legacy systems, improve auditability, and standardize workflows across global teams.
The business is primarily subscription-based, with additional revenue from professional services that support implementation and customer adoption. Veeva operates as a vertical cloud software provider, meaning its growth depends on continued digital transformation in life sciences, expansion of its product suite, and the ability to deepen relationships with large global customers while remaining useful to smaller emerging biotech companies.
Last updated
- Market Cap
- 29.86B
- P/E
- 32.85
- P/FCF
- 21.54
- P/S
- 9.34
- Enterprise Value
- 28.43B
- Sector
- Industrials
- Industry
- Prepackaged Software
- Address
- 4280 HACIENDA DRIVE, PLEASANTON, CA, 94588
Accumulus Technologies gibt die Live-Integration mit Veeva RIM bekannt und ermöglicht damit eine nahtlose Verbindung zwischen RIM und den Aufsichtsbehörden
Accumulus Technologies annonce la mise en service de son intégration avec Veeva RIM, permettant une connexion fluide entre les systèmes RIM et les autorités réglementaires
Clinical Trial Management System Research Report 2026: $4.2 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Artificial Intelligence Clinical Trial Protocol Feasibility Tool Research Report 2026: $2.75+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035F
Clinical Trial Software Research Report 2026: $2.5+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Pharmacovigilance Market Size to Reach USD 24.69 Billion by 2035 Owing to the Surging Demand for Drug Safety Monitoring Solutions Globally
Clinical Trials Support Software Solutions in a $34.15B Trial Economy by 2035
Down 20%: These 3 Software Stocks Are Boosting Buybacks
Electronic Clinical Outcome Assessment Solutions Market Projected to Reach USD 5.64 Billion by 2032 at a CAGR of 15.3% - SNS Insider
HealthEx appoints Jeremy Schwarz as Chief Commercial Officer
BlackRock Fund Dividend Reset Offers 9.2% Yield at a Discount
Close-Up International Appoints Jim Barone as Executive Vice President of Business Solutions to Continue Launch into US Pharma CRM Market
Accumulus Synergy and Veeva Systems Partner to Advance Regulatory Transformation and Connectivity
Accumulus Synergy et Veeva Systems s’associent afin d’accélérer la transformation réglementaire et la connectivité
eClinical Solutions Market Size to Lead USD 40,500 Million by 2034, Growth in the Biopharmaceutical and Pharmaceutical Industry
Europe Pharmacovigilance and Drug Safety Software Market Forecast, Regional Share and Growth Opportunity Analysis to 2031
Veeva Systems names new CFO in leadership shakeup By Investing.com - Investing.com Canada
Reasons to Retain Veeva Systems (VEEV) in Your Portfolio Now - Zacks Investment Research
Veeva Systems CMO resigns, interim leader planned - Investing.com
Why Veeva Systems (VEEV) is a Top Growth Stock for the Long-Term
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 29.86B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 28.43B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 32.85
- P/B
P/B ratio compares a company's share price to its book value per share.
- 4.14
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 9.34
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 29.79
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 8.9
- EPS
- 5.57
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 21.54
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 21.1
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 1.39B
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 12.6%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 10.12%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 4.89
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 4.89
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.87
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 3.87M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 182.94
Income Statement
| Line Item | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 |
|---|---|---|---|---|---|
| Revenue | 835.95M | 811.24M | 789.08M | 759.04M | 720.89M |
| Gross profit | 622.47M | 611.77M | 593.83M | 585.22M | 539.9M |
| Operating income | 245.88M | 240.85M | 195.91M | 233.73M | 188.42M |
| EBITDA | 254.19M | 250.56M | 206.03M | 243.55M | 198.36M |
| Net income | 244.2M | 236.2M | 200.31M | 228.19M | 195.63M |
| Basic EPS | 1.49 | 1.44 | 1.23 | 1.4 | 1.2 |
| Diluted EPS | 1.48 | 1.4 | 1.19 | 1.37 | 1.17 |
Balance Sheet
| Line Item | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 |
|---|---|---|---|---|---|
| Total assets | 8.98B | 8.1B | 8B | 7.77B | 7.34B |
| Total liabilities | 1.76B | 1.06B | 1.36B | 1.55B | 1.51B |
| Total equity | 7.21B | 7.04B | 6.64B | 6.21B | 5.83B |
| Cash & equivalents | 1.42B | 1.66B | 1.93B | 1.96B | 1.12B |
| Current assets | 8B | 7.11B | 6.99B | 6.71B | 6.31B |
| Current liabilities | 1.64B | 944.88M | 1.26B | 1.46B | 1.4B |
Cash Flow
| Line Item | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 |
|---|---|---|---|---|---|
| Operating cash flow | 106.85M | 192.79M | 238.43M | 877.16M | 69.54M |
| Investing cash flow | -167.75M | -495.23M | -389.27M | -52.11M | -15.69M |
| Financing cash flow | -178.05M | 32.65M | 115.69M | 20.38M | 20.81M |
| Change in cash | -238.9M | -270.29M | -34.55M | 846.2M | 74.27M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | DEF 14A — VEEVA SYSTEMS INC | View Filing | |
| edgar index | DEFA14A — VEEVA SYSTEMS INC | View Filing | |
| edgar index | ARS — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| form 4 | Form 4 — Hung Priscilla | View Filing | |
| edgar index | 8-K — VEEVA SYSTEMS INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 144 — VEEVA SYSTEMS INC | View Filing | |
| form 4 | Form 4 — Hung Priscilla | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| form 4 | Form 4 — Faddis Jonathan | View Filing | |
| form 4 | Form 4 — Kondath Vipin | View Filing | |
| form 4 | Form 4 — Kondath Vipin | View Filing | |
| form 4 | Form 4 — Schwenger Thomas D. | View Filing | |
| form 4 | Form 4 — Schwenger Thomas D. | View Filing | |
| form 4 | Form 4 — Van Wagener Brian | View Filing | |
| form 4 | Form 4 — Van Wagener Brian | View Filing | |
| form 4 | Form 4 — Zuppas Eleni Nitsa | View Filing | |
| form 4 | Form 4 — Zuppas Eleni Nitsa | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| form 4 | Form 4 — Faddis Jonathan | View Filing | |
| form 4 | Form 4 — Faddis Jonathan | View Filing | |
| form 4 | Form 4 — Faddis Jonathan | View Filing | |
| form 4 | Form 4 — Faddis Jonathan | View Filing | |
| form 4 | Form 4 — Faddis Jonathan | View Filing | |
| form 4 | Form 4 — Faddis Jonathan | View Filing | |
| form 4 | Form 4 — Zuppas Eleni Nitsa | View Filing | |
| form 4 | Form 4 — Zuppas Eleni Nitsa | View Filing | |
| form 4 | Form 4 — Zuppas Eleni Nitsa | View Filing | |
| form 4 | Form 4 — Zuppas Eleni Nitsa | View Filing | |
| form 4 | Form 4 — Zuppas Eleni Nitsa | View Filing | |
| form 4 | Form 4 — Zuppas Eleni Nitsa | View Filing | |
| form 4 | Form 4 — Kondath Vipin | View Filing | |
| form 4 | Form 4 — Kondath Vipin | View Filing | |
| form 4 | Form 4 — Kondath Vipin | View Filing | |
| form 4 | Form 4 — Kondath Vipin | View Filing | |
| form 4 | Form 4 — Kondath Vipin | View Filing | |
| form 4 | Form 4 — Kondath Vipin | View Filing | |
| form 4 | Form 4 — Schwenger Thomas D. | View Filing | |
| form 4 | Form 4 — Schwenger Thomas D. | View Filing | |
| form 4 | Form 4 — Schwenger Thomas D. | View Filing | |
| form 4 | Form 4 — Van Wagener Brian | View Filing | |
| form 4 | Form 4 — Van Wagener Brian | View Filing | |
| form 4 | Form 4 — Van Wagener Brian | View Filing | |
| edgar index | SCHEDULE 13G/A — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 10-K — VEEVA SYSTEMS INC | View Filing | |
| edgar index | S-8 — VEEVA SYSTEMS INC | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| form 4 | Form 4 — Schwenger Thomas D. | View Filing | |
| edgar index | 8-K — VEEVA SYSTEMS INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| edgar index | 4 — VEEVA SYSTEMS INC | View Filing | |
| form 4 | Form 4 — Ritter Gordon | View Filing | |
| form 4 | Form 4 — Ritter Gordon | View Filing | |
| form 4 | Form 4 — Ritter Gordon | View Filing | |
| form 4 | Form 4 — Ritter Gordon | View Filing |